TOBI Networks Names DataBiologics its Official Outcomes Platform
The OrthobioIogic Institute (TOBI) has endorsed DataBiologics as the official outcomes software of its network. This alliance re-affirms TOBI’s commitment to promoting evidence-based care and physician collaboration in the field of regenerative medicine.
Members of TOBI Network can now leverage DataBiologics’ simple and powerful outcomes platform to track and analyze their own patient’s progress while contributing to a global registry in order to advance innovative orthopedic treatments.
DataBiologics makes it easy to collect Patient Reported Outcomes (PROs) to allow for more informed treatment decisions and better patient care. Currently DataBiologics supports modalities for tracking over a dozen innovative treatments including Platelet Rich Plasma (PRP), Bone Marrow Aspirate Concentrate (BMAC), Prolotherapy and Shock Wave therapy.
“Partnering with DataBiologics will provide the global TOBI Networks Community with a turnkey solution to track patient outcomes,” says Steven E. Sampson, DO., Founder of The Orthobiologic Institute (TOBI). “Regenerative Medicine 2.0 will incorporate widespread data capture for more transparency of results and promote customized treatment plans. Adding DataBiologics to our platform supports our mission of partnering with industry to advance the field.”
DataBiologics seeks to become the standard platform and largest repository for all physicians performing regenerative orthopedic treatments. Together with networks like TOBI, and individual physicians and researchers across the globe, they are working to leverage this comprehensive data to:
- Enhance orthobiologic quality of care
- Improve patient outcomes and safety
- Demonstrate the safety and effectiveness of current orthobiologic treatments
- Improve when and how regenerative therapies and orthobiologics are provided in the future
- And ultimately to improve orthopedic care for patients
“We are delighted to partner with TOBI Networks which is dedicated to sharing the science and best practices in the cutting edge field of orthobiologics,” says Nancy Ho, Executive Director of DataBiologics. “With TOBI’s expertise in the orthobiologics industry and our advanced software capabilities, we will provide physicians the tools and data they need to collaborate and improve patient care.”
DataBiologics will demonstrate their platform and the benefits to TOBI members at and following the TOBI 12th Annual 2021 Online Orthobiologics Symposium, October 8–9, 2021. As part of this new partnership, members of TOBI Network will receive preferred pricing. Contact DataBiologics for a demo or more details: info@databiologics.com.
About The Orthobiologic Network (TOBI) The Orthobiologic Institute was founded to share best practices in biologics research and orthopedic applications. TOBI promotes a high-quality, standardized approach to biologic treatments, to advance the field, and gain recognition as viable, effective treatment.
About DataBiologics DataBiologics offers doctors a robust Patient-Reported Outcomes collection platform to study the safety and efficacy of orthobiologic treatments. The simple, user-friendly, and practical application helps assist doctors in collecting real-world, patient data to allow for more informed treatment decisions and better patient care.
